Navigation Links
Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs

Indian and Chinese doctors will collaborate to prove through clinical trials the efficacy of some traditional herbal drugs that have for generations// been known to cure but for which there is no scientific evidence.

"The protocol of the first such collaboration has been approved by the board members and the final draft report is soon to be submitted to the government for seeking funding," said Ranjit Roy Chaudhury, chair of the Indian Clinical Epidemiology Network (INCLEN) board of trustees and US-based non-profit organisation INCLEN Inc.

"The project protocol has been signed and we will soon be ready to submit it to authorities for seeking funds," Chaudhury told IANS.

The Indian Council of Medical Research (ICMR) is among the organisations looked at for funding. The first joint clinical research will bring together a number of Indian institutes, including the Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, the ICMR, the INCLEN Trust, and the Centre for Evaluation of Traditional Ayurvedic Medicine.

The Chinese collaboration will be led by Ji-Yao Yang of Shanghai Medical College attached to Zhangshajn Hospital at Fudan University in Shanghai.

While not accepting or rejecting the claims of traditional herbal medicinal cures, a large team of specialists, including V.S Mathur, a professor of pharmacology and advisor to Chaudhury, and PGI Director K.K. Talwar, will make efforts to scientifically test the efficacy and safety of herbal drugs.

Non-insulin dependent Diabetes II and inflammatory bowel diseases are medical problems for which the various herbal drugs are to be tested initially. Later, other herbal drugs for hepatitis, HIV/AIDS and other diseases will be taken up for testing.

One of the herbal drugs to be tested is 'gymnema sylvetra', known as 'gurmara booti', meaning destroyer of diabetes. Raisins from gymnema sylvetra plant, found mostly in the so uthern region, has been recommended for use for centuries in controlling diabetes.

In India, the clinical trials, expected to take around 18-24 months, will be conducted at PGI Chandigarh under supervision to monitor the efficacy of the drug, standardisation of plants and the dosage of drugs.

"Unlike in China, our medical students have little exposure to herbal medicines during their MBBS, due to which there is considerable scepticism among Indian doctors about their use as alternative or complimentary medicine," said Chaudhury, who will visit China in June to initiate the study.

The protocol approved by the INCLEN envisages extending the collaboration to other countries like Thailand and Mexico.

It is not just in India and China that herbal drugs are used extensively for ailments and improvement in health but also in the US, where studies have revealed that every third person uses some herbal preparations.

The US herbal drug market, promoted as food supplements, is estimated to be worth around $4-5 billion, said Mathur, who has spent a major part of his life in Bahrain where he taught pharmacology.

"According to the Current Medical Diagnosis and Treatment, considered a bible for medical practitioners, around 30 percent of allopathic drugs originate from herbs," said Mathur.

"Once this clinical trial has been completed and the scientific documentations completed to show the efficacy and safety of the ayurvedic drugs, the results would be accepted by the world community," he said.

The clinical trial will start with a shorter three-month to six-month clinical trial to lay down the methodology of how the herbal drugs are to be tested, the toxicology and its efficacy.

"As these drugs have been used for hundreds of years, we do not see any reason to expect any adverse reaction. If required we will go in for a detailed study to find out how to purify and standardise the ingredients," said Mathur.

Some of the specialists involved in the effort to scientifically test the herbal drugs have been engaged in such an exercise by observing patients who have switched to herbal remedies with allopathic medicines having not provided any relief.

--Edited IANS
'"/>




Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2017)... OH (PRWEB) , ... February 19, 2017 , ... Braun ... The JEMS Conference & Exposition, the event will take place February 23-25, 2017 at ... Industries will be in Booth #909 with three new ambulances on display. ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... home healthcare, will join forces with Healthwise ® at HIMSS 2017 ... the industry leader in evidence-based health education, technology and services, will demonstrate a ...
(Date:2/18/2017)... ... ... Butler Mobility invited Ken Matthews to visit its manufacturing facility and showroom ... impressed with the safety and reliability of the Stannah Stairlift as well as with ... endorsement by Ken Matthews can be heard on News Radio WHP 580 weekdays from ...
(Date:2/18/2017)... ... February 18, 2017 , ... ProParagraph Fashion Volume 2 ... ’ ProParagraph Fashion Volume 2 for all multi-line FCPX project needs. Great ... pick and choose from hand-crafted trend-setting designs with smooth animations that will add ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... kept pace. Enovate Medical has introduced an innovative workstation designed to reduce nursing ... nurses, the Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... According to a new market research report "Particle Counters Market ... Contamination Monitoring of Liquids), and End User (Healthcare Industry, Semiconductor Industry) ... expected to reach USD 330.6 Million by 2021 from USD 275.9 ... 2021. Continue Reading ... ...
(Date:2/17/2017)... , Feb. 17, 2017 Theravance ... Biopharma" or the "Company") today announced the presentation ... potent, and orally administered pan-Janus kinase (JAK) inhibitor ... th Congress of the European Crohn,s and ... Company reported further data from its completed Phase ...
(Date:2/17/2017)... -- Research and Markets has announced the addition of the ... their offering. ... separate comprehensive analytics for the US, Canada , ... , and Rest of World. Annual estimates and forecasts are provided ... provided for these markets. Market data and analytics are derived from primary ...
Breaking Medicine Technology: